Product Information
TRAVOPROST 0.004% EYE DROP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $9.7475 per ML under NDC 68462094305. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Jul 12, 2024. Its Orange Book therapeutic-equivalence code is AT2.
Strength
.04 mg/mL
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462094305
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TRAVOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA218159FDA Approved
7/12/2024
TE Code
AT2
On Market Since
9/30/2024
Pharmacological Classes
Price Statistics
The NADAC for TRAVOPROST 0.004% EYE DROP has been published 94 times since Dec 18, 2024, and over the history we have for it it has declined 29.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7475 per ML |
|---|---|
| All-time high | $15.2383 (Feb 12, 2025) |
| All-time low | $8.4375 (Jul 22, 2026) |
| 52-week high | $10.9937 |
| 52-week low | $8.4375 |
| Median price | $10.7845 |
| Average price | $11.3914 |
| Largest weekly change | -10.8% (Apr 23, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Travoprost Ophthalmic Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAVOPROST 0.004% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TRAVOPROST 0.004% EYE DROP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $9.7475 per ML (NDC 68462094305), effective Sep 30, 2026.
How has the price of TRAVOPROST 0.004% EYE DROP changed over time?
Over the history we have for it, the NADAC for TRAVOPROST 0.004% EYE DROP has declined 29.4%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for TRAVOPROST 0.004% EYE DROP?
Since Dec 18, 2024, the NADAC for TRAVOPROST 0.004% EYE DROP has ranged from a low of $8.4375 (Jul 22, 2026) to a high of $15.2383 (Feb 12, 2025), with a median of $10.7845 per ML.
Are there cheaper alternatives to TRAVOPROST 0.004% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAVOPROST 0.004% EYE DROP, is $8.3941 per ML — about 14% below TRAVOPROST 0.004% EYE DROP.
Who manufactures TRAVOPROST 0.004% EYE DROP?
TRAVOPROST 0.004% EYE DROP (NDC 68462094305) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.